Beyond debacle and debate: developing solutions in drug safety.
- Published in:
- 2009
- By:
- Publication type:
- review
Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 10
Results: 23
1
2
New approaches to drug safety: a pharmacovigilance tool kit.
- Published in:
- 2009
- By:
- Publication type:
- review
3
Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.
- Published in:
- 2009
- By:
- Publication type:
- journal article
4
Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.
- Published in:
- 2009
- By:
- Publication type:
- journal article
5
Fibrotic disease: A pair of novel targets.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 773, doi. 10.1038/nrd3005
- By:
- Publication type:
- Article
6
Psoriasis market.
- Published in:
- 2009
- By:
- Publication type:
- journal article
7
Dronedarone.
- Published in:
- 2009
- By:
- Publication type:
- journal article
8
Neuroscience R&D.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 825, doi. 10.1038/nrd3001
- Publication type:
- Article
9
Market watch: Upcoming market catalysts in Q4 2009.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 763, doi. 10.1038/nrd3004
- By:
- Publication type:
- Article
10
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 783, doi. 10.1038/nrd2959
- By:
- Publication type:
- Article
11
Neurodegenerative disorders: A biomarker and a target for progressive MS.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 771, doi. 10.1038/nrd3006
- By:
- Publication type:
- Article
12
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 774, doi. 10.1038/nrd3007
- Publication type:
- Article
13
Drug metabolism: Microbial metabolite predicts human metabolism.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 772, doi. 10.1038/nrd3008
- By:
- Publication type:
- Article
14
Santhera licenses novel dyskinesia therapy to Biovail.
- Published in:
- 2009
- Publication type:
- journal article
15
Late-stage osteoporosis drugs illustrate challenges in the field.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 757, doi. 10.1038/nrd3015
- By:
- Publication type:
- Article
16
Morgan Sheng.
- Published in:
- 2009
- Publication type:
- Interview
17
Lessons from the lung for targeted anticancer drugs.
- Published in:
- 2009
- By:
- Publication type:
- journal article
18
Patent watch.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 764, doi. 10.1038/nrd3017
- By:
- Publication type:
- Article
19
Mixed results for novel CD20-targeted antibody.
- Published in:
- 2009
- Publication type:
- journal article
20
In this issue.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 753, doi. 10.1038/nrd3020
- Publication type:
- Article
21
The evolution of trial registration.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 755, doi. 10.1038/nrd3021
- Publication type:
- Article
22
Autoimmune disease: SIRT1 keeps escapees quiet.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 772, doi. 10.1038/nrd3022
- By:
- Publication type:
- Article
23
Stem cells: Tailored drug screening.
- Published in:
- Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 774, doi. 10.1038/nrd3023
- By:
- Publication type:
- Article